Proxy Votes Now

Home › Funds › Simplify Health Care ETF

Simplify Health Care ETF (PINK) proxy voting record 2025-2026

Fund family: Simplify Exchange Traded Funds · Filed by Simplify Exchange Traded Funds (CIK 1810747) · SEC series S000073751

Ticker: PINK (C000230898)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 559 with, 18 against, 0 abstentions (not counted as with management). Shareholder proposals: 0 FOR, 15 AGAINST, 0 abstained, by the filing’s own vote-source field.

No item-level comparison with other Simplify Exchange Traded Funds funds is possible: no ballot item of this fund was voted by at least three other funds of the family with a clear majority.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 86.7% of this fund’s 577 such votes could be given a sector; the other 77 (13.3%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care391174.3%
Industrials7200.0%
Consumer Discretionary2000.0%
Consumer Staples1715.9%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections3833
Audit-related570
Say-on-Pay520
Compensation381
Corporate Governance1810
Capital Structure150
Shareholder Rights and Defenses133
Other Social Issues21

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
ELI LILLY AND COMPANYMay 4, 2026$28M102
UNITED THERAPEUTICS CORPORATIONJune 26, 2026$20M150
10X GENOMICS, INC.June 4, 2026$19M50
ALIGN TECHNOLOGY, INC.May 20, 2026$18M130
ABBVIE INC.May 8, 2026$15M81
JOHNSON & JOHNSONApril 23, 2026$15M151
THERMO FISHER SCIENTIFIC INC.May 20, 2026$12M130
GILEAD SCIENCES, INC.April 30, 2026$11M153

Notable votes against management

MeetingCompanyProposalFundMgmt
May 4, 2026ELI LILLY AND COMPANYShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalAgainstFor
May 4, 2026ELI LILLY AND COMPANYShareholder proposal to prepare an annual lobbying report. Shareholder proposalAgainstFor
May 8, 2026ABBVIE INC.Stockholder Proposal - to Adopt a Policy to Require an Independent Chair Shareholder proposalAgainstFor
April 23, 2026JOHNSON & JOHNSONIndependent Board Chair Shareholder proposalAgainstFor
April 30, 2026GILEAD SCIENCES, INC.To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
April 30, 2026GILEAD SCIENCES, INC.To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
May 19, 2026AMGEN INC.Stockholder proposal to require an independent board chairman. Shareholder proposalAgainstFor
May 13, 2026VERTEX PHARMACEUTICALS INCORPORATEDShareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposalAgainstFor
May 14, 2026CVS HEALTH CORPORATIONStockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposalAgainstFor
April 23, 2026IQVIA HOLDINGS INC.If properly presented, a stockholder proposal concerning separate Chairman and Chief Executive Officer roles. Shareholder proposalAgainstFor
June 9, 2026PACIRA BIOSCIENCES, INC.DOMA Nominees Opposed by the Company: Oliver Benton Curtis IIIWithholdFor
June 9, 2026PACIRA BIOSCIENCES, INC.DOMA Nominees Opposed by the Company: Eric de ArmasWithholdFor

Contested meetings

Meetings with a proxy contest or competing nominees (1 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

578 ballot items at 57 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Simplify Health Care ETF (PINK) voted at 57 shareholder meetings of 55 companies, on 578 ballot items in all. Where management made a recommendation, the fund followed it on 96.9% of the items and voted against it 18 times. Its most frequent area of disagreement was corporate governance (10 of its votes against management). It voted on 15 shareholder proposals. 1 of its meetings was contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.